Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1994-4-21
|
pubmed:abstractText |
Human immunodeficiency virus type 1 (HIV-1) gp-120 potentially plays an important role in inducing functional suppression and depletion of CD4 lymphocytes following infection with HIV. In order to further understand the mechanisms involved in HIV-induced immunosuppression, we have studied the effects of recombinant HIV-1 gp120/SF2 and anti-gp120/SF2 antibodies on T cell receptor (TCR)-mediated proliferation of peripheral blood mononuclear cells (PBMCs) and isolated lymphocyte subsets from HIV-seronegative donors. In a dose-dependent manner, gp120 significantly reduces the proliferative responses of unfractionated PBMCs and highly enriched CD4 T lymphocytes when they are polyclonally stimulated through the TCR using WT31 (anti-alpha beta Ti chains) and anti-Leu 4 (anti-CD3 epsilon) in the presence of autologous accessory cells. The addition of divalent anti-gp120/SF2 to lymphocytes previously incubated with gp120 further reduces the proliferation to the levels seen after pretreating cells with divalent anti-CD4 (anti-Leu 3a). CD8 T lymphocytes, on the other hand, show no change in TCR-mediated proliferation following preincubation with either anti-CD4 or gp120/anti-gp120. We find no evidence for significant cell death by apoptosis using methods of DNA analysis or flow cytometry and DNA-specific dyes to account for the loss of CD4 lymphocyte proliferation. Interleukin-2 restores the proliferation suppressed by gp120/anti-gp120 suggesting the induction of reversible functional anergy.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD4,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Envelope Protein gp120,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0894-9255
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
340-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7907660-Antibodies, Monoclonal,
pubmed-meshheading:7907660-Antigens, CD4,
pubmed-meshheading:7907660-CD4-Positive T-Lymphocytes,
pubmed-meshheading:7907660-Cell Survival,
pubmed-meshheading:7907660-Dose-Response Relationship, Immunologic,
pubmed-meshheading:7907660-HIV Antibodies,
pubmed-meshheading:7907660-HIV Envelope Protein gp120,
pubmed-meshheading:7907660-HIV Seronegativity,
pubmed-meshheading:7907660-HIV-1,
pubmed-meshheading:7907660-Humans,
pubmed-meshheading:7907660-Interleukin-2,
pubmed-meshheading:7907660-Leukocytes, Mononuclear,
pubmed-meshheading:7907660-Lymphocyte Activation,
pubmed-meshheading:7907660-Lymphocyte Subsets,
pubmed-meshheading:7907660-Receptors, Antigen, T-Cell,
pubmed-meshheading:7907660-Recombinant Proteins
|
pubmed:year |
1994
|
pubmed:articleTitle |
HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes.
|
pubmed:affiliation |
Department of Laboratory Medicine, University of California, San Francisco.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|